Optimizing Acyclic Identification of Aptamers
暂无分享,去创建一个
[1] Ettore Novellino,et al. High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity , 2012, Nucleic acids research.
[2] Sam F. Y. Li,et al. Selection of aptamers for signal transduction proteins by capillary electrophoresis , 2010, Electrophoresis.
[3] D. Guyer,et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.
[4] V. Erdmann,et al. Mirror-image RNA that binds D-adenosine , 1996, Nature Biotechnology.
[5] A. Tulinsky,et al. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. , 1994, The Journal of biological chemistry.
[6] T. Brown,et al. Biocompatible artificial DNA linker that is read through by DNA polymerases and is functional in Escherichia coli , 2011, Proceedings of the National Academy of Sciences.
[7] Michael Musheev,et al. Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. , 2005, Journal of the American Chemical Society.
[8] M Yarus,et al. Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.
[9] A. Van Schepdael,et al. Selection and Characterization of DNA Aptamers for Egg White Lysozyme , 2010, Molecules.
[10] Victor Okhonin,et al. Selection of smart aptamers by methods of kinetic capillary electrophoresis. , 2006, Analytical chemistry.
[11] Michael B. Mathews,et al. A mechanism for the control of protein synthesis by adenovirus VA RNAI , 1986, Cell.
[12] Volker A. Erdmann,et al. Mirror-design of L-oligonucleotide ligands binding to L-arginine , 1996, Nature Biotechnology.
[13] M. Cosgrove,et al. On the Mechanism of Multiple Lysine Methylation by the Human Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex*♦ , 2009, The Journal of Biological Chemistry.
[14] R. Jenison,et al. Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion. , 1998, Antisense & nucleic acid drug development.
[15] L. C. Bock,et al. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. , 1993, Blood.
[16] P. Giangrande,et al. Therapeutic applications of DNA and RNA aptamers. , 2009, Oligonucleotides.
[17] A. Ellington,et al. Binding of herpes simplex virus-1 US11 to specific RNA sequences , 2005, Nucleic acids research.
[18] D. Murray,et al. DNA-protein crosslinks: their induction, repair, and biological consequences. , 2005, Mutation research.
[19] A. Heeger,et al. Micromagnetic selection of aptamers in microfluidic channels , 2009, Proceedings of the National Academy of Sciences.
[20] Hua-Zhong Yu,et al. Design and testing of aptamer-based electrochemical biosensors for proteins and small molecules. , 2009, Bioelectrochemistry.
[21] Zoltán Konthur,et al. Probing the SELEX Process with Next-Generation Sequencing , 2011, PloS one.
[22] F. Eckstein,et al. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. , 1991, Science.
[23] A D Ellington,et al. Isozyme-specific inhibition of protein kinase C by RNA aptamers. , 1994, The Journal of biological chemistry.
[24] Paul J. Hatala,et al. DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER , 2007 .
[25] S. Klußmann,et al. Polyetheylenimine-Polyplexes of Spiegelmer NOX-A50 Directed against Intracellular High Mobility Group Protein A1 (HMGA1) Reduce Tumor Growth in Vivo* , 2010, The Journal of Biological Chemistry.
[26] J. Lis,et al. New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization , 2014, Molecular therapy. Nucleic acids.
[27] Anthony D. Keefe,et al. Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. , 2005, Chemistry & biology.
[28] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[29] S. Gopinath. Methods developed for SELEX , 2006, Analytical and bioanalytical chemistry.
[30] H. Gralnick,et al. The carbohydrate of human thrombin: structural analysis of glycoprotein oligosaccharides by mass spectrometry. , 1983, Archives of biochemistry and biophysics.
[31] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[32] Stephen A. Williams,et al. Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer , 2010, PloS one.
[33] J. Bruno. Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics , 2015, Molecules.
[34] B. Cosmi. ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent. , 2009, Current opinion in molecular therapeutics.
[35] R. Kuchta,et al. Polymerization of 2'-fluoro- and 2'-O-methyl-dNTPs by human DNA polymerase alpha, polymerase gamma, and primase. , 2000, Biochemical pharmacology.
[36] Michael Musheev,et al. Non-SELEX selection of aptamers. , 2006, Journal of the American Chemical Society.
[37] S. Klußmann,et al. A DNA Spiegelmer to staphylococcal enterotoxin B. , 2003, Nucleic acids research.
[38] Dong-Ki Lee,et al. A sol-gel-based microfluidics system enhances the efficiency of RNA aptamer selection. , 2011, Oligonucleotides.
[39] Weihong Tan,et al. Nucleic acid aptamers for biosensors and bio-analytical applications. , 2009, The Analyst.
[40] Mauricio G. Cohen,et al. The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome. , 2012, Future cardiology.
[41] C H Heldin,et al. Inhibitory DNA ligands to platelet-derived growth factor B-chain. , 1996, Biochemistry.
[42] M. Willis,et al. Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. , 2000, Journal of biotechnology.
[43] Liguang Xu,et al. Building an aptamer/graphene oxide FRET biosensor for one-step detection of bisphenol A. , 2015, ACS applied materials & interfaces.
[44] L. Gold,et al. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Steitz,et al. Sno Storm in the Nucleolus: New Roles for Myriad Small RNPs , 1997, Cell.
[46] J. Keene,et al. Exploring molecular diversity with combinatorial shape libraries. , 1994, Trends in biochemical sciences.
[47] S. Klußmann,et al. An L-RNA-based aquaretic agent that inhibits vasopressin in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. M. Healy,et al. First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers , 2007, Circulation.
[49] David D. Smith,et al. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. , 2011, Methods.
[50] Allen D. Delaney,et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing , 2007, Nature Methods.
[51] M. Bowser,et al. In vitro evolution of functional DNA using capillary electrophoresis. , 2004, Journal of the American Chemical Society.
[52] C. Lorenz,et al. Genomic systematic evolution of ligands by exponential enrichment (Genomic SELEX) for the identification of protein-binding RNAs independent of their expression levels , 2006, Nature Protocols.
[53] A. Ellington,et al. Adapting selected nucleic acid ligands (aptamers) to biosensors. , 1998, Analytical chemistry.
[54] V. C. Ozalp,et al. Aptamers: molecular tools for medical diagnosis. , 2015, Current topics in medicinal chemistry.
[55] Carlotta Guiducci,et al. More DNA-Aptamers for Small Drugs: A Capture-SELEX Coupled with Surface Plasmon Resonance and High-Throughput Sequencing. , 2015, ACS combinatorial science.
[56] Catherine Lozupone,et al. Selection of the simplest RNA that binds isoleucine. , 2003, RNA.
[57] Penmetcha K. R. Kumar,et al. Molecular beacon aptamer fluoresces in the presence of Tat protein of HIV‐1 , 2000, Genes to cells : devoted to molecular & cellular mechanisms.
[58] Andrew D. Ellington,et al. Nucleic Acid Selection and the Challenge of Combinatorial Chemistry. , 1997, Chemical reviews.
[59] E. Wang,et al. Highly sensitive and specific colorimetric detection of cancer cells via dual-aptamer target binding strategy. , 2015, Biosensors & bioelectronics.
[60] Anthony D. Keefe,et al. Aptamers as candidate therapeutics for cardiovascular indications. , 2008, Current opinion in pharmacology.
[61] J. Szostak,et al. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures , 1992, Nature.
[62] R. Knight,et al. Analyzing partially randomized nucleic acid pools: straight dope on doping. , 2003, Nucleic acids research.
[63] P. Schimmel,et al. Protein synthesis editing by a DNA aptamer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[64] K. Thompson,et al. 2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics. , 2006, Oligonucleotides.
[65] R. Y. Tsai,et al. Identification of DNA Recognition Sequences and Protein Interaction Domains of the Multiple-Zn-Finger Protein Roaz , 1998, Molecular and Cellular Biology.
[66] D. Wagner,et al. Inhibition of von Willebrand factor‐mediated platelet activation and thrombosis by the anti‐von Willebrand factor A1‐domain aptamer ARC1779 , 2009, Journal of thrombosis and haemostasis : JTH.
[67] R. Sousa,et al. A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs. , 2002, Nucleic acids research.
[68] D. M. Brown,et al. An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. , 1996, Journal of molecular biology.
[69] T. Yokoyama,et al. Characterization and application of a novel RNA aptamer against the mouse prion protein. , 2006, Journal of biochemistry.
[70] Matthew C. Cowperthwaite,et al. Bioinformatic Analysis of the Contribution of Primer Sequences to Aptamer Structures , 2008, Journal of Molecular Evolution.
[71] C. Ferreira,et al. DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers , 2006, Tumor Biology.
[72] Robert Langer,et al. Nanotechnology and Aptamers: Applications in Drug Delivery , 2022 .
[73] M Yarus,et al. Three small ribooligonucleotides with specific arginine sites. , 1993, Biochemistry.
[74] D. Shangguan,et al. Development of DNA aptamers using Cell-SELEX , 2010, Nature Protocols.
[75] B. Cullen,et al. Regulatory pathways governing HIV-1 replication , 1989, Cell.
[76] Seung Soo Oh,et al. Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing , 2010, Proceedings of the National Academy of Sciences.
[77] Nadia Nikolaus,et al. Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics , 2012, Journal of analytical methods in chemistry.
[78] M. Bowser,et al. Capillary electrophoresis-SELEX selection of catalytic DNA aptamers for a small-molecule porphyrin target. , 2013, Analytical chemistry.
[79] J. Feigon,et al. Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[80] Jon Ashley,et al. Selection of bovine catalase aptamers using non‐SELEX , 2012, Electrophoresis.
[81] Gary A. Clawson,et al. The Shorter the Better: Reducing Fixed Primer Regions of Oligonucleotide Libraries for Aptamer Selection , 2009, Molecules.
[82] G. Clawson,et al. Minimal primer and primer-free SELEX protocols for selection of aptamers from random DNA libraries. , 2008, BioTechniques.
[83] A. Ellington,et al. Aptamer beacons for the direct detection of proteins. , 2001, Analytical biochemistry.
[84] K. Scherrer,et al. A rapid and sensitive method for detection of proteins in polyacrylamide SDS gels: Staining with ethidium bromide , 1979, Molecular Biology Reports.
[85] Jesse Dabney,et al. Length and GC-biases during sequencing library amplification: a comparison of various polymerase-buffer systems with ancient and modern DNA sequencing libraries. , 2012, BioTechniques.
[86] G. F. Joyce,et al. Deep sequencing analysis of mutations resulting from the incorporation of dNTP analogs , 2010, Nucleic acids research.
[87] R. Schultz,et al. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties. , 1996, Nucleic acids research.
[88] Sheela M. Waugh,et al. 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.
[89] Seung Soo Oh,et al. Generation of highly specific aptamers via micromagnetic selection. , 2009, Analytical chemistry.
[90] Abhishek Parashar,et al. Aptamers in Therapeutics. , 2016, Journal of clinical and diagnostic research : JCDR.
[91] E. Ng,et al. Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases , 2006, Annals of the New York Academy of Sciences.
[92] L. Gold,et al. Interactions of Escherichia coli RNA with bacteriophage MS2 coat protein: genomic SELEX. , 2000, Nucleic acids research.
[93] Magda Tsolaki,et al. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. , 2013, Journal of Alzheimer's disease : JAD.
[94] S. Niranjanakumari,et al. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. , 2002, Methods.
[95] T. Yeates,et al. Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG). , 1996, Journal of molecular biology.
[96] Kevin W Plaxco,et al. Structure-switching biosensors: inspired by Nature. , 2010, Current opinion in structural biology.
[97] George Quick,et al. Antidote-mediated control of an anticoagulant aptamer in vivo , 2004, Nature Biotechnology.
[98] A. Ellington,et al. Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA , 2004, Nature Biotechnology.
[99] S. Swaminathan,et al. A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA. , 1993, Biochemistry.
[100] L. J. Maher,et al. Selection and characterization of an RNA decoy for transcription factor NF-kappa B. , 1999, Biochemistry.
[101] Larry Gold,et al. Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents , 2014, Molecular therapy. Nucleic acids.
[102] L. Gold,et al. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[103] B. Jilma,et al. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease , 2010, Thrombosis and Haemostasis.
[104] J C Cox,et al. Automated selection of anti-protein aptamers. , 2001, Bioorganic & medicinal chemistry.
[105] Michael Famulok,et al. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. , 2007, Chemical reviews.
[106] Stephen A. Williams,et al. Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool , 2012, PloS one.
[107] Primer-free aptamer selection using a random DNA library. , 2010, Methods in molecular biology.
[108] M. Bowser,et al. In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. , 2004, Analytical chemistry.
[109] Kemin Wang,et al. Label-free and turn-on aptamer strategy for cancer cells detection based on a DNA-silver nanocluster fluorescence upon recognition-induced hybridization. , 2013, Analytical chemistry.
[110] A. Tulinsky,et al. An ambiguous structure of a DNA 15-mer thrombin complex. , 1996, Acta crystallographica. Section D, Biological crystallography.
[111] A D Ellington,et al. In Vitro Selection of RNA Molecules That Inhibit the Activity of Ricin A-chain* , 2000, The Journal of Biological Chemistry.
[112] J. Eikelboom,et al. Coagulation Factor IXa as a Target for Treatment and Prophylaxis of Venous Thromboembolism , 2010, Arteriosclerosis, Thrombosis and Vascular Biology.
[113] Juewen Liu,et al. Aptamer-based biosensors for biomedical diagnostics. , 2014, The Analyst.
[114] Christopher B. Burge,et al. Direct visualization of DNA affinity landscapes using a highthroughput sequencing instrument , 2011 .
[115] M. Price,et al. Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting. , 2005, Journal of immunological methods.
[116] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.
[117] A. Schwienhorst. Direct thrombin inhibitors – a survey of recent developments , 2006, Cellular and Molecular Life Sciences CMLS.
[118] Jack W. Szostak,et al. An RNA motif that binds ATP , 1993, Nature.
[119] M. Sandros,et al. Zeptomole Detection of C-Reactive Protein in Serum by a Nanoparticle Amplified Surface Plasmon Resonance Imaging Aptasensor , 2014, Scientific Reports.
[120] R. Knight,et al. Size, constant sequences, and optimal selection. , 2005, RNA.
[121] L. Gold,et al. Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool. , 1995, Virology.
[122] Peter J. Woolf,et al. A Mechanistic Model of PCR for Accurate Quantification of Quantitative PCR Data , 2010, PloS one.
[123] M. Zourob,et al. Aptamer-based label-free impedimetric biosensor for detection of progesterone. , 2015, Analytical chemistry.
[124] Mark P. McPike,et al. Acyclic Identification of Aptamers for Human alpha-Thrombin Using Over-Represented Libraries and Deep Sequencing , 2011, PloS one.
[125] F. Luo,et al. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. , 2007, Biochemical and biophysical research communications.
[126] J. Hope,et al. Characterization of 2′-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion* , 2003, Journal of Biological Chemistry.
[127] K. Adelman,et al. In vitro selection of packaging sites in a double-stranded RNA virus , 1997, Journal of virology.
[128] J C Cox,et al. Automated RNA Selection , 1998, Biotechnology progress.
[129] M. Bowser,et al. In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. , 2005, Journal of the American Chemical Society.
[130] Andrew D. Ellington,et al. Surface-immobilized aptamers for cancer cell isolation and microscopic cytology. , 2010, Cancer research.
[131] Tracy R. Keeney,et al. Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, Nature Precedings.
[132] Yingfu Li,et al. Recognition of anionic porphyrins by DNA aptamers. , 1996, Biochemistry.
[133] M. Fischer,et al. Just in time-selection: A rapid semiautomated SELEX of DNA aptamers using magnetic separation and BEAMing. , 2014, Analytical chemistry.
[134] B. Sullenger,et al. A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function , 2008, Angiogenesis.
[135] J. Shendure,et al. A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes. , 2014, Journal of molecular biology.
[136] I Karube,et al. In vitro selection of DNA aptamers which bind to cholic acid. , 2000, Biochimica et biophysica acta.
[137] A. Aitken,et al. The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M* , 2000, The Journal of Biological Chemistry.
[138] M. Buckle,et al. DNA-protein interactions : a practical approach , 2000 .
[139] Zhaofeng Luo,et al. In vitro selection of high-affinity DNA aptamers for streptavidin. , 2009, Acta biochimica et biophysica Sinica.
[140] Edouard E Galyov,et al. Development of aptamers specific for potential diagnostic targets in Burkholderia pseudomallei. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[141] George Georgiou,et al. Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. , 2002, Nucleic acids research.
[142] S. Klußmann,et al. Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist , 2005, Nucleic acids research.
[143] John T McDevitt,et al. Aptamer-based sensor arrays for the detection and quantitation of proteins. , 2004, Analytical chemistry.
[144] B. Sullenger,et al. RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.
[145] Anca M. Segall,et al. In Vitro Selection of Integration Host Factor Binding Sites , 1999, Journal of bacteriology.
[146] M. Bowser,et al. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. , 2005, Analytical chemistry.
[147] Letha J. Sooter,et al. Automated acquisition of aptamer sequences. , 2002, Combinatorial chemistry & high throughput screening.
[148] In vitro selection of RNA aptamers. , 2000, Methods in enzymology.
[149] Y. Zu,et al. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy , 2014, Molecular therapy. Nucleic acids.
[150] J. Swenberg,et al. Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers. , 2010, Journal of the American Chemical Society.
[151] K K Kidd,et al. Modeling of heteroduplex formation during PCR from mixtures of DNA templates. , 1992, PCR methods and applications.
[152] B. Gatto,et al. In vitro selection of DNA aptamers that bind L-tyrosinamide. , 2001, Bioorganic & medicinal chemistry.
[153] E. Vermaas,et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.
[154] Y. Iwakura,et al. RNA packaging signal of human immunodeficiency virus type 1. , 1992, Virology.
[155] S. Klußmann,et al. Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. , 2003, Nucleic acids research.
[156] K. Machida,et al. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. , 1997, Virology.
[157] T. Hianik,et al. Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin. , 2007, Bioelectrochemistry.
[158] Han Wei Hou,et al. Identification of malaria parasite-infected red blood cell surface aptamers by inertial microfluidic SELEX (I-SELEX) , 2015, Scientific Reports.
[159] Christopher M Rose,et al. Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragment. , 2010, The Analyst.
[160] E. Gilboa,et al. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay , 2010, Nature.
[161] L. Kèlland,et al. Discovery and development of anticancer aptamers , 2006, Molecular Cancer Therapeutics.
[162] S. Klußmann,et al. Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(®) therapeutics. , 2015, Drug discovery today.
[163] R. Sousa,et al. Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'-groups using a mutantT7 RNA polymerase (RNAP). , 1999, Nucleic acids research.
[164] B. Eaton,et al. The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets. , 1997, Current opinion in chemical biology.
[165] M. Cosgrove,et al. Biochemical Reconstitution and Phylogenetic Comparison of Human SET1 Family Core Complexes Involved in Histone Methylation* , 2015, The Journal of Biological Chemistry.